{"database": "press", "table": "releases", "rows": [["https://www.ricketts.senate.gov/news/press-releases/ricketts-slotkin-introduce-legislation-to-prevent-offshoring-biotech-industry-to-communist-china/", "Ricketts, Slotkin Introduce Legislation to Prevent Offshoring Biotech Industry to Communist China", "2026-08-06", "2026", "2026-08", "Republican", "Senate", "NE", "Pete Ricketts", "R000618", "www.ricketts.senate.gov", "ricketts", "https://www.ricketts.senate.gov/newsroom/press-releases/?jsf=jet-engine:press-list&pagenum=", "scraper", "WASHINGTON, D.C. \u2013 Today, U.S. Senators Pete Ricketts (R-NE) and Elissa Slotkin (D-MI) introduced the Biotech Investment National Security Act (BINSA). This bill would ensure American investment in adversary biotechnology is subject to the review requirements of the Comprehensive Outbound Investment National Security (COINS) Act.\n\nSpecifically, this legislation adds biotechnology, including pharmaceutical development, biologics manufacturing, and clinical research to the list of sectors subject to screening.\n\n\u201cAmerica leads the world in innovation across all sectors,\u201d said Senator Ricketts. \u201cThis critical legislation ensures American investment in the biotech industry benefits Americans\u2014not our enemies. We cannot allow Communist China to obtain the resources it needs to threaten our way of life. I will fight every effort that weaponizes American investments to undercut our businesses and reshape supply chains against us. Maintaining America\u2019s innovative leadership and global economic dominance is a matter of national security.\u201d\n\n\u201cBiotech is crucial for driving economic growth, creating jobs, and spurring innovation in science and technologies, like lifesaving medicines,\u201dsaid Senator Slotkin.\u201cBut right now, China is eating our lunch in this field. This bill ensures strong U.S. leadership in biotech and protects U.S. intellectual property and investments. We\u2019ve seen China use this playbook before to dominate other critical sectors, such as the automotive industry and drone market. This bill will stop that.\u201d\n\nThis legislation would:\n\nAmend the COINS Act to include biotechnology \u2013specifically pharmaceutical and biological product development\u2014to the list of sectors subject to outbound screening.\n\nMake U.S. pharmaceutical licensing deals, joint ventures, and equity investments with Chinese covered foreign persons subject to review by the U.S. Treasury Department.\n\nDirect the Treasury Department to consult with Health and Human Services (HHS), the Department of War (DoW), and the Director of National Intelligence (DNI) and implement regulations within one year of enactment.\n\nRequire the Secretary of Defense to assess within 60 days whether U.S. capital flows into Chinese biotechnology negatively affect national security and military readiness.\n\nCompanion legislation was introduced in the House by Reps. John Moolenaar (R-MI-02) and Debbie Dingell (D-MI-06) in June 2026.", 1, "2026-08-07T06:11:19Z", "2026-08-07T06:12:42Z"]], "columns": ["url", "title", "date", "year", "month", "party", "chamber", "state", "member_name", "bioguide_id", "domain", "scraper", "source", "date_source", "text", "has_text", "collected_at", "updated_at"], "primary_keys": ["url"], "primary_key_values": ["https://www.ricketts.senate.gov/news/press-releases/ricketts-slotkin-introduce-legislation-to-prevent-offshoring-biotech-industry-to-communist-china/"], "units": {}, "query_ms": 0.7559030782431364, "source": "dwillis/congress-press", "source_url": "https://github.com/dwillis/congress-press", "license": "MIT", "license_url": "https://github.com/dwillis/congress-press/blob/main/LICENSE"}